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Original article
Can we early diagnose metabolic syndrome using brachial-ankle 
pulse wave velocity in community population?
Li Xin, Zheng Liang, Wu Juanli, Ma Yunsheng, Masanori Munakata, Oleski Jessica, Zhang Lijuan, Wo Da, 
Wang Jingsong, Jiang Qiaoyu, Zou Liling, Liu Xuebo and Li Jue
Keywords: brachial-ankle pulse wave velocity; metabolic syndrome; receiver operating characteristic curve 
Background  The prevalence of metabolic syndrome (MetS) increased recently and there was still not a screening index 
to predict MetS. The aim of this study was to estimate whether brachial-ankle pulse wave velocity (baPWV), a novel 
marker for systemic arterial stiffness, could predict MetS in Chinese community population. 
Methods  A total of 2 191 participants were recruited and underwent medical examination including 1 455 men and 756 
women from June 2011 to January 2012. MetS was diagnosed according to the criteria of the International Diabetes 
Federation (IDF). Multiple Logistic regressions were conducted to explore the risk factors of MetS. Receiver operating 
characteristic (ROC) curve was performed to estimate the ideal diagnostic cutoff point of baPWV to predict MetS. 
Results  The mean age was (45.35±8.27) years old. In multiple Logistic regression analysis, the gender, baPWV and 
smoking status were risk factors to MetS after adjusting age, gender, baPWV, walk time and sleeping time. The prevalence 
of MetS was 17.48% in 30-year age population in Shanghai. There were significant differences (χ2=96.46, P <0.05) 
between male and female participants on MetS prevalence. According to the ROC analyses, the ideal cutoff point of 
baPWV was 1 358.50 cm/s (AUC=60.20%) to predict MetS among male group and 1 350.00 cm/s (AUC=70.90%) among 
female group. 
Conclusion  BaPWV may be considered as a screening marker to predict MetS in community Chinese population and the 
diagnostic value of 1 350.00 cm/s was more significant for the female group.
Chin Med J 2014;127 (17): 3116-3120
Metabolic syndrome (MetS), consisting of abdominal obesity, atherogenic dyslipidemia, high blood 
pressure, and hyperglycemia, has now received a great 
interest because its number is increasing in broad area of 
the world.1-3 Although it has been a controversial topic, 
MetS has been identified as an important and common 
cluster of risk factors of cardiovascular diseases (CVD) and 
coronary heart disease (CHD) by some organizations4-6 such 
as the International Diabetes Federation (IDF), the World 
Health Organization (WHO), and the National Cholesterol 
Education Program’s Adult Treatment Panel (NCEP). In 
recent years, MetS has been commonly used in large-scale 
studies around the world.7,8
With the development in economy and changes in life 
style, the prevalence of MetS has been on the rise over 
the past few decades in China.9-11 The prevalence of 
MetS is 16.5% in the mainland of China11 and 15.8% in 
Taiwan, China12 among adult population according to IDF 
definition. Currently, MetS has become a serious disease 
to the society and families not only in China, but also in 
other countries. However, there is still no precise data on 
total prevalence in Chinese, especially among middle aged 
and elderly population due to the lack of useful diagnostic 
tool. Therefore, it is necessary to establish a measure 
to early diagnose MetS. Arterial stiffness is a vascular 
marker including whole cardiovascular risks3 and could be 
a diagnostic tool for Mets. In the present study, brachial-
ankle pulse wave velocity (baPWV), a novel measure for 
systemic arterial stiffness, was employed13 to predict MetS.
METHODS
Study population
Participants were included if they met the following 
criteria: (1) Subjects aged ≥30 years; (2) Individuals who 
were community residents in Lujiazui, Shanghai; (3) 
Participants without hypertension crisis, multiple system 
organ failure, or other disease that was unavailable to 
measure baPWV. Pregnant women were excluded from the 
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present study. From June 2011 to January 2012, a total of 
2 191 participants were recruited and underwent medical 
examination including 1 455 male and 756 female. The 
protocol was approved by the Ethical Committee of Tongji 
University Medical School. All participants gave written 
informed consent.
Laboratory measurements
Systolic blood pressure (SBP), diastolic blood pressure 
(DBP), body mass index (BMI), levels of fasting plasma 
glucose (FPG), hemoglobin A1c (HbA1c) and high-density 
lipoprotein (HDL) were measured in all subjects. Plasma 
total cholesterol, HDL cholesterol, HbA1c and blood 
glucose were measured enzymatically.9 All blood samples 
were obtained in the morning after fasting overnight.
BaPWV measurement
A clinical device (Colin VP1000, Komaki, Japan) has been 
developed to automatically and simultaneously measure 
blood pressure (BP) in both ankles and arms, as record 
pulse waves of the brachial and posterior tibial arteries 
using an automated oscillometric method.14,15 Using this 
device, we can easily obtain the baPWV values. It was 
measured after the subject had rested for at least 5 minutes. 
Validation of this method has been previously reported.16-18 
We adopted the value of right baPWV in the present study.
Definition of varaibles
MetS was defined according to the following criteria: (1) 
required criteria: BMI ≥25 kg/m2 (the waist circumference 
was not available in this study). (2) Plus any two of 
the following four factors: elevated triglyceride level: 
≥1.7 mmol/L (or 150 mg/dl); reduced HDL cholesterol: 
<40 mg/dl (male) or 50 mg/dl (female); elevated blood 
pressure (≥130/85 mmHg), and fasting plasma glucose 
≥5.6 mmol/L (or 100 mg/dl). Or they had been diagnosed 
as dyslipidemia, hypertension and diabetes mellitus with 
specific treatment for these abnormalities.19-21
Statistical analysis
Continuous data were expressed as the mean±standard 
deviation (SD). For the continuous variables, t-test was 
employed to analyze the difference between groups. For 
the categorized variables, χ2-test was conducted to show 
the ratio difference between two groups. ROC curve 
analysis was also performed to discriminate patients with 
or without MetS disease by baPWV. Then, the values with 
the highest sum of sensitivity and specificity were identified 
as the cutoff values. The step-wise Logistic regression 
analysis was conducted to explore risk factors of MetS. 
All statistical analysis was performed using the SAS (SAS 
Institute, USA) and SPSS (SPSS Inc., USA) software 
package. P <0.05 was considered as statistically significant.
RESULTS
A total of 2 191 subjects were enrolled in our study 
between June 2011 and January 2012 in Shanghai. The 
demographic data, physical characteristics, and mean 
values of biochemical indictors of two groups (MetS group 
and non-MetS group) are shown in Table 1. The baseline 
demography of target population showed that mean age of 
patients was (45.35±8.27) years and the age of the MetS 
group was higher than the control group (t=5.42, P <0.05). 
There were significant differences in the constituent ratio 
of, education level, smoking, alchohol, diabetes history, 
hypertension history and CHD history between two groups 
(P <0.05), but no differences in folk and marriage status 
between two groups (P >0.05).  
Table 1 also revealed the laboratory test value and clinical 
characteristics of research participants. The BMI value of 






Age (years) 47.37±7.95 44.86±8.27 5.42 0.001
Folk (n (%)) 3.23 0.072
    Han 371 (98.40) 1 782 (99.30)
    Other 6 (1.60) 12 (0.70)
Marriage status 0.145 0.704
    Single 8 (2.10) 44 (2.50)
    Other 368 (97.90) 1 746 (97.50)
Education level 4.48 0.034
    Low 249 (65.5) 1 271 (29.0)
    High 131 (34.5) 519 (71.0)
Smoking (n (%)) 45.53 0.001
    Yes 174 (45.70) 504 (28.00)
    No 207 (54.30) 1 293 (72.00)
Alcohol (n (%)) 39.80 0.001
    Yes 172 (45.50) 519 (28.85)
    No 206 (54.50) 1 278 (71.15)
Walking time (h/d) 2.07±0.81 2.05±0.79 0.53 0.590
Sleeping time (h/d) 7.24±3.91 7.25±2.50 –0.04 0.950
Diabetes (n (%)) 112.24 0.001
Yes 127 (33.16) 126 (6.97)
No 256 (66.84) 1 682 (93.03)
Hypertension (n (%)) 218.25 0.001
    Yes 254 (66.32) 488 (26.99)
    No 129 (3.68) 1 320 (73.01)
CHD history (n (%)) 55.23 0.001
    Yes 66 (17.05) 104 (5.80)
    No 323 (82.95) 1 685 (94.20)
BMI (kg/m2) 27.53±2.21 23.31±2.74 28.24 0.001
SBP (mmHg) 136.86±16.33 122.12±15.53 16.70 0.001
HR (beats/min) 73.59±11.30 73.10±10.79 0.81 0.419
HbA1c (%) 5.74±1.12 5.27±0.75 7.76* 0.001
FPG (mmol/L) 5.42±1.51 4.79±0.95 7.81 0.001
LDL-C (mmol/L) 3.03±0.81 2.85±0.70 4.19 0.001
HDL-C (mmol/L) 1.13±0.44 1.27±0.34 –7.76 0.001
UA (µmol/L) 388.61±83.76 321.60±87.90 13.66 0.001
UN (mmol/L) 5.24±1.13 5.11±1.20 2.02 0.054
AST (U/L) 28.13±19.71 22.69±10.81 4.20* 0.001
ALT (U/L) 35.21±11.93 23.84±21.39 9.26* 0.001
baPWV (cm/s) 1 431.75±247.90 1 315.53±212.01 5.59 0.001
ABI 1.08±0.07 1.05±0.08 3.37 0.001
Data were expressed as mean±SD or n (percent). *The variances were not equal 
between two groups. Folk: Study participants was divided into Han and other 
minor ethic people. Education level, Low: less than education of 12 years; High: 
more than education of 12 years. BMI: body mass index; SBP: systolic blood 
pressure; HR: heart rate; HbA1c: hemoglobin A1c; FPG: fasting plasma glucose; 
LDL-C: low density lipoprotein cholesterol; HDL-C: how density lipoprotein 
cholesterol; UA: uric acid; UN: urine nitrogen; AST: aspartate aminotransferase; 
ALT: alanine aminotransferase; BaPWV: brachial-ankle pulse wave velocity; 
ABI: ankle-brachial index. Walking time: the walking time outdoor.
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MetS group was higher than that of control group (t=28.24, 
P <0.05). The lab test items SBP, HbA1c and other 
variables were significant higher in MetS group. However, 
HDL cholesterol was higher in the female group (t= –7.76, 
P <0.05). 
In total, ROC curve analysis indicated that the cutoff point 
was 1 350 cm/s and AUC was 0.65 (95% CI: 0.568, 0.637) 
for the whole groups. However, the ROC curve analysis 
revealed there were different diagnosis effects for different 
gender groups (Figure 1). AUC was 0.60 (95% CI: 0.568, 
0.637) in male group and 0.71 (95% CI: 0.636, 0.795) in 
female group respectively. Compared with the male group, 
the diagnosis value of baPWV cutoff point was more 
significant to predict MetS in female group.
In present study, 1 350 cm/s was considered as a point to 
divide baPWV into high value and low value according to 
ROC analysis results in total group. The Logistic regression 
model indicated that baPWV was an important risk of 
MetS in three models not only for the men but also for 
the women. Among model 2, baPWV and smoking were 
entered into the final regression model for men. Their 
OR value were 1.82 and 1.14 (Table 2). Among model 
3, baPWV and smoking also were risk factors for the 
men while age and walking time were risk factors for the 
women. 
The prevalence of MetS was 17.48% in present study 
population in Shanghai. The prevalence of MetS was more 
common in men than in women in all generations (Table 3, 
P <0.05). The Chi-square test for trend indicated prevalence 
of MetS in different gender groups was closer with the 
increasing age group (χ2=10.40, P <0.05). The prevalence 
of MetS was rapidly rising with age increasing in female 
group, but not in male group.
Table 4 demonstrates the changing trend of positive/
negative likelihood ratio and Yodan index according to 
different BaPWV cutoff point. When 
BaPWV was equal to 1 350 cm/s, the results 
were ideal. These results confirmed the 
cutoff value coming from ROC analysis. 
Its positive likelihood ratio and negative 
likelihood ratio was 1.35 and 0.73 for 
the men (2.12 and 0.64 for the women) 
respectively. 
DISCUSSION
Previous studies have indicated that MetS 
was strongly associated with significant 
coronary artery stenosis, mixed plaque 
formation and multivessel involvement.3,4 
In present study, CHD history in MetS 
group was higher than that in control group 
and this result was consistent with above 
conclusion. At the same time, baPWV might 
predict the development of atherosclerosis 
and it has been verified by several studies. Then we 
assumed that baPWV could be a screening index to predict 
the MetS.
ROC analysis showed that baPWV may be considered as a 
screening marker to predict MetS among middle-aged and 
Figure 1. The ROC curves to predict MetS according to gender. A: Male group. 
Cutoff point=1 358.5 cm/s. AUC=0.60, 95% CI: 0.568, 0.637. Sensitivity=58.7%; 
Specificity=57.3%. B: Female group. Cutoff point=1 350cm/s. AUC=0.71, 95% CI: 
0.636, 0.795. Sensitivity=50.5%; Specificity=74.5%.
Table 2. Risk factors of MetS in Logistic regression analysis 
according to three models
Variables β SE Wald P values OR 95% CI
Men 
    Model 1
        baPWV 0.56 0.12 19.79 0.000 1.75 1.37, 2.25
    Model 2
        Age group –0.03 0.08 0.19 0.655 0.96 0.80, 1.14
        baPWV 0.59 0.13 19.56 0.000 1.82 1.39, 2.37
        Marriage –0.19 0.47 0.16 0.682 0.82 0.32, 2.09
        Smoking 0.13 0.06 4.40 0.035 1.14 1.01, 1.30
    Model 3
        Age group –0.05 0.08 0.28 0.596 0.95 0.80, 1.13
        baPWV 0.63 0.13 21.70 0.000 1.89 1.44, 2.47
        Marriage –0.20 0.47 0.18 0.671 0.81 0.32, 2.08
        Smoking 0.15 0.06 5.24 0.022 1.16 1.02, 1.32
        Walking time 0.02 0.08 0.07 0.781 1.02 0.86, 1.21
        Sleeping time 0.01 0.02 0.07 0.786 1.00 0.96, 1.04
Women 
    Model 1
        baPWV 0.73 0.30 5.68 0.017 2.07 1.13, 3.78
    Model 2
        Age group 0.81 0.21 13.82 0.111 2.26 1.47, 3.47
        baPWV 0.38 0.32 1.39 0.237 1.46 0.77, 2.77
        Marriage –1.04 0.73 2.00 0.157 0.35 0.08, 1.49
        Smoking 0.21 0.55 0.15 0.694 1.24 0.42, 3.67
    Model 3
        Age group 0.83 0.23 13.03 0.000 2.29 1.46, 3.60
        baPWV 0.43 0.33 1.67 0.195 1.54 0.80, 2.98
        Marriage –1.32 0.78 2.83 0.092 0.26 0.05, 1.24
        Smoking 0.16 0.58 0.08 0.771 1.18 0.37, 3.73
        Walking time 0.51 0.17 8.28 0.004 1.66 1.17, 2.36
        Sleeping time –0.00 0.05 0.00 0.939 0.99 0.89, 1.11
BaPWV (men): high value (baPWV≥1 350 cm/s), low value (baPWV<1 350 cm/s). 
BaPWV (women): high value (baPWV≥1 350 cm/s), low value (baPWV<1 350 
cm/s). Adjusted variable in model 1: baPWV. Adjusted variables in model 2: 
age, baPWV, marriage, smoking. Adjusted variables in model 3: age, baPWV, 
marriage, smoking, walking time, sleeping time.
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elderly population. Its diagnosis value was more significant 
in the female group. The cutoff point was 1 358.50 cm/s for 
the men and 1 350 cm/s for the women while it was 1 350 
cm/s for the whole group. When considered 1 350 cm/s 
as the best cutoff value in total groups, multiple logistic 
regression results revealed that baPWV and smoking were 
risk factors causing to MetS for the men while age and 
walking time were risk factors for the women. 
Using the IDF definition, we assessed the prevalence 
of MetS among 30-year old population in Shanghai. 
Approximately 17.48% of participants met the criteria of 
MetS. This result was higher than the prevalence of 12.1% 
reported by Wang et al22 and 14.6% reported by Li et al.23 
In contrast, it was lower than the results (prevalence of 
19.4%) made by Weng et al.24 On the other hand, we are 
aware that the study group is not necessarily representative 
of the general population since it is a selective elderly based 
community population. Therefore, we assume that the 
prevalence of MetS in the general population in Shanghai 
might be even lower than present results.
It was interesting that there were significant differences 
in prevalence among the different gender groups in the 
present study. The prevalence of male group was higher 
than female group among all age groups. Above results 
suggested that male group have higher risk to MetS than 
female group. This means that females may be a protective 
factor to MetS. We propose the main reason being the 
arterial stiffness of male participants was worse than female 
group for the present research. It also means that the degree 
of inflammation was higher in the male group. At the 
same time, the BMI, blood press, glucose and low-density 
lipoprotein cholesterol were lower among female group. 
With an increase in age, the trend became closer on 
prevalence. Different researches had controversial results 
to this conclusion. In researches reported by Zhao et al,25,26 
they also showed the prevalence of MetS was higher in 
men than in women. While the research conducted by Gu 
et al11 indicated the opposite results.
Although MetS has attracted the attention coming from 
several international organizations, there was still not a 
suitable diagnosed marker to predict this disease. As a 
good marker of atherosclerosis, baPWV may be a potential 
diagnose tool to the MetS, especially to the 30-year old 
individuals.
There was a strong relationship between MetS and 
atherosclerosis in previous studies.27 The mechanisms 
underlying the association between MetS and arterial 
stiffness28 were likely that they have the same important 
pre-steps (inflammation and oxidative stress appearance). 
Several researches28-31 indicated that inflammation and 
oxidative stress could contribute to the progress of MetS 
and atherosclerosis.
 As we acknowledge, there were few researches to consider 
baPWV as a screening tool to predict the MetS among 
middle-aged and elderly population and ROC analysis 
indicated its diagnosis value was more significant in the 
female group. Another novel finding was that females 
could be a protective factor to causing MetS. The positive/
negative likelihood ratio and Youden index also confirmed 
the 1 350 cm/s was the best cutoff value not only for men 
but for women.
There were also several limitations in present studies. 
Firstly, we could overestimate the prevalence of male group 
since its mean age was higher than female group. Secondly, 
our discoveries could not definitively prove a cause link 
underlying the association described above since it was 
a cross-sectional study. Thirdly, we could not promise 
that we have ruled out residual confounding of other 
unknown factors. Therefore, it is necessary to have further 
prospective studies for a better explanation. 
In conclusion, baPWV may be considered as a screening 
marker to predict the MetS among middle-aged and elderly 
population and the diagnosis value was more significant to 
the female group (cutoff point=1 350 cm/s). In our daily 
life, we should pay attention in preventing MetS through 
controlling baPWV and quitting smoking, especially in 
men.
Acknowledgements: We are grateful to all subjects for their 
enthusiastic participation. We are also indebted to Xiu Jianfeng and 
Wu Lezou for their pioneering work. 
REFERENCES
1. Fung GJ, Steffen LM, Zhou X, Harnack L, Tang W, Lutsey PL, 
et al. Vitamin D intake is inversely related to risk of developing 
Table 4. Cutoff point of BaPWV and its positive/negative likelihood 
ratio by gender
BaPWV Sensitivity Specificity LR+ LR– Youden index
Men
1 250 0.83 0.30 1.17 0.59 0.12
1 300 0.70 0.42 1.21 0.71 0.12
1 350* 0.58 0.57 1.35 0.73 0.15
1 400 0.50 0.65 1.43 0.77 0.15
1 450 0.42 0.73 1.58 0.56 0.15
Women 
1 250 0.67 0.57 1.55 0.57 0.22
1 300 0.56 0.68 1.75 0.64 0.24
1 350* 0.51 0.76 2.12 0.64 0.27
1 400 0.32 0.84 2.00 0.81 0.16
1 450 0.22 0.88 1.83 0.89 0.10
LR+: positive likelihood ratio; LR–: negative likelihood ratio. *Best cutoff point 
of baPWV.




Men  Women  
χ2 P valuesMetS (%) Non-MetS (%) MetS (%) Non-MetS (%)
30–39 65 (19.88) 262 (80.12) 7 (1.15) 276 (97.53) 44.14 0.000
40–49 131 (24.86) 396 (75.14) 25 (7.65) 302 (92.35) 40.04 0.000
50– 138 (23.71) 444 (76.29) 17 (11.72) 128 (88.28) 9.94 0.001
Total 334 (23.26) 1 102 (76.74) 49 (6.49) 706 (82.52) 96.46 0.000
Chi-square test for trend: χ2=10.40, P <0.05.
Chin Med J 2014;127 (17)3120
metabolic syndrome in African American and white men and 
women over 20 y: the Coronary Artery Risk Development in 
Young Adults study. Am J Clin Nutr 2012; 96: 24-29.
2. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, 
Yeckel CW, et al. Obesity and the metabolic syndrome in 
children and adolescents. N Engl J Med 2004; 350: 2362-2374.
3. Willemse PM, Burggraaf J, Hamdy NA, Weijl NI, Vossen CY, 
van Wulften L, et al. Prevalence of the metabolic syndrome and 
cardiovascular disease risk in chemotherapy-treated testicular 
germ cell tumour survivors. Br J Cancer 2013; 109: 60-67.
4. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, 
Donato KA, et al. Harmonizing the metabolic syndrome: a joint 
interim statement of the International Diabetes Federation Task 
Force on Epidemiology and Prevention; National Heart, Lung, 
and Blood Institute; American Heart Association; World Heart 
Federation; International Atherosclerosis Society; and Interna-
tional Association for the Study of Obesity. Circulation 2009; 
120: 1640-1645.
5. Green DJ, O’Driscoll G, Joyner MJ, Cable NT. Exercise and 
cardiovascular risk reduction: time to update the rationale for 
exercise? J Appl Physiol (1985) 2008; 105: 766-768.
6. Sabo RT, Lu Z, Deng X, Ren C, Daniels S, Arslanian S, et al. 
Parental and offspring associations of the metabolic syndrome in 
the Fels Longitudinal Study. Am J Clin Nutr 2012; 96: 461-466.
7. Kim K, Yang YJ, Kim K, Kim MK. Interactions of single 
nucleotide polymorphisms with dietary calcium intake on the 
risk of metabolic syndrome. Am J Clin Nutr 2012; 95: 231-240.
8. Astell KJ, Mathai ML, McAinch AJ, Stathis CG, Su XQ. A pilot 
study investigating the effect of Caralluma fimbriata extract on 
the risk factors of metabolic syndrome in overweight and obese 
subjects: a randomised controlled clinical trial. Complement 
Ther Med 2013; 21: 180-189.
9. Zong G, Ye X, Sun L, Li H, Yu Z, Hu FB, et al. Associations 
of erythrocyte palmitoleic acid with adipokines, inflammatory 
markers, and the metabolic syndrome in middle-aged and older 
Chinese. Am J Clin Nutr 2012; 96: 970-976.
10. Chen J, Gu D, Huang J, Rao DC, Jaquish CE, Hixson JE, et 
al. Metabolic syndrome and salt sensitivity of blood pressure 
in non-diabetic people in China: a dietary intervention study. 
Lancet 2009; 373: 829-835.
11. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, et al. 
Prevalence of the metabolic syndrome and overweight among 
adults in China. Lancet 2005; 365: 1398-1405.
12. Sun F, Tao QS, Zhan SY. Comparison of five different diagnostic 
criteria on metabolic syndrome applied during physical check-up 
programs among population aged 35–74, in Taiwan (in Chinese). 
Chin J Epidemiol 2008; 29: 925-929.
13. Su HM, Lin TH, Hsu PC, Chu CY, Lee WH, Chen SC, et al. 
Impact of systolic time intervals on the relationship between 
arterial stiffness and left ventricular hypertrophy. Atherosclerosis 
2012; 223: 171-176.
14. Kang S, Fan HM, Li J, Fan LY, Miao AY, Bao Y, et al. Relation-
ship of arterial stiffness and early mild diastolic heart failure in 
general middle and aged population. Eur Heart J 2010; 31: 2799-
2807.
15. Weng C, Yuan H, Yang K, Tang X, Huang Z, Huang L, et al. 
Gender-specific association between the metabolic syndrome 
and arterial stiffness in 8,300 subjects. Am J Med Sci 2013; 346: 
289-294.
16. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose 
K, et al. Validity, reproducibility, and clinical significance of 
noninvasive brachial-ankle pulse wave velocity measurement. 
Hypertens Res 2002; 25: 359-364.
17. Paik JK, Kim M, Kwak JH, Lee EK, Lee SH, Lee JH. Increased 
arterial stiffness in subjects with impaired fasting glucose. J 
Diabetes Complications 2013; 27: 224-228.
18. Munakata M, Ito N, Nunokawa T, Yoshinaga K. Utility of au-
tomated brachial ankle pulse wave velocity measurements in 
hypertensive patients. Am J Hypertens 2003; 16: 653-657.
19. Lim H, Nguyen T, Choue R, Wang Y. Sociodemographic dis-
parities in the composition of metabolic syndrome components 
among adults in South Korea. Diabetes Care 2012; 35: 2028-
2035.
20. Cohen E, Krause I, Fraser A, Goldberg E, Garty M. Hyperurice-
mia and metabolic syndrome: lessons from a large cohort from 
Israel. Isr Med Assoc J 2012; 14: 676-680.
21. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome--a new 
worldwide definition. Lancet 2005; 366: 1059-1062.
22. Wang ZW, Wang X, Li X, Chen Z, Zhao LC, Li Y, et al. Preva-
lence and trend of metabolic syndrome in middle-aged Chinese 
population (in Chinese). Chin J Epidemiol 2009; 30: 596-600.
23. Li Y, Zhao D, Wang W, Wang WH, Sun JY, Qin LP, et al. A com-
parison of three diagnostic criterions for metabolic syndrome 
applied in a Chinese population aged 35–64 in 11 provinces  (in 
Chinese). Chin J Epidemiol 2007; 28: 83-87.
24. Weng C, Yuan H, Tang X, Huang Z, Yang K, Chen W, et al. 
Age- and gender dependent association between components of 
metabolic syndrome and subclinical arterial stiffness in a Chi-
nese population. Int J Med Sci 2012; 9: 730-737.
25. Zhao J, Pang ZC, Zhang L, Gao WG, Wang SJ, Ning F, et al. 
Prevalence of metabolic syndrome in rural and urban Chinese 
population in Qingdao. J Endocrinol Invest 2011; 34: 444-448.
26. Shao J, Yu L, Shen X, Li D, Wang K. Waist-to-height ratio, an 
optimal predictor for obesity and metabolic syndrome in Chinese 
adults. J Nutr Health Aging 2010; 14: 782-785.
27. Tok D, Kadife I, Turak O, Ozcan F, Basar N, Cagli K, et al. In-
creased epicardial fat thickness is associated with low grade sys-
temic inflammation in metabolic syndrome. Turk Kardiyol Dern 
Ars 2012; 40: 690-695.
28. Zhang Y, Chen J, Zhang K, Kong M, Wang T, Chen R, et al. 
Inflammation and oxidative stress are associated with the preva-
lence of high aankle-brachial index in metabolic syndrome pa-
tients without chronic renal failure. Int J Med Sci 2013; 10: 183-
190.
29. Vita JA, Keaney JF, Larson MG, Keyes MJ, Massaro JM, 
Lipinska I, et al. Brachial artery vasodilator function and 
systemic inflammation in the Framingham Offspring Study. 
Circulation 2004; 110: 3604-3609.
30. Rizvi AA. Inflammation markers as mediators of vasculo-
endothelial dysfunction and atherosclerosis in the metabolic syn-
drome. Chin Med J 2007; 120: 1918-1924.
31. Cao HL, Chen XB, Lu JG, Hou ZH, Tang X, Gao Y, et al. Meta-
bolic syndrome and coronary artery calcification: a community-
based natural population study. Chin Med J 2013; 126: 4618-
4623.
(Received April 8, 2014)
Edited by Guo Lishao
